Physician profile
David C Rish
NPI 1225045438
$962.06
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $115 · 2021: $118 · 2022: $186 · 2023: $144 · 2024: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $231.05 | 2023-2024 | |
| Galderma Laboratories, L.P. | $122.10 | 2019-2022 | |
| Amgen INC. | $99.96 | 2020-2023 | Otezla |
| Pfizer INC. | $95.12 | 2021-2022 | |
| Epi Health, LLC | $92.44 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $75.31 | 2019-2021 | |
| Allergan, INC. | $74.68 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $68.98 | 2019-2022 | |
| Leo Pharma INC. | $53.63 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $26.04 | 2023 | Libtayo |
| Arcutis Biotherapeutics, INC. | $22.75 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.